SCHEMBL16654289

SCHEMBL16654289

CC1Sc2cc(Cl)ccc2N1P(=O)(O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 1/20 0.35
▸ NR4A1 P22736 1/20 0.35
▸ HSD17B3 P37058 1/20 0.34
▸ GRIA1 P42261 2/20 0.33
▸ GRIA2 P42262 2/20 0.33
▸ GRIA3 P42263 2/20 0.33
▸ GRIA4 P48058 2/20 0.33
▸ TAS1R3 Q7RTX0 1/20 0.33
▸ TAS1R1 Q7RTX1 1/20 0.33
▸ TAS1R2 Q8TE23 1/20 0.33
▸ NOTUM Q6P988 1/20 0.31
▸ SNCA P37840 1/20 0.31
▸ BCHE P06276 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ OPRK1 P41145 1/20 0.30
▸ PDE3A Q14432 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11516330 0.74 GRIA1 (0.41) MYCNR4A1HSD17B3GRIA1GRIA2
SCHEMBL1165819 0.69 GRIA1 (0.36) MYCNR4A1HSD17B3GRIA1GRIA2
SCHEMBL10508972 0.64 ALOX15 (0.41) —
SCHEMBL27034742 0.64 GRIA1 (0.38) GRIA1GRIA2GRIA3GRIA4CYP1A2
SCHEMBL28094908 0.64 GRIA1 (0.39) MYCNR4A1HSD17B3GRIA1GRIA2
SCHEMBL1049587 0.64 GRIA1 (0.41) GRIA1GRIA2GRIA3GRIA4CYP1A2
SCHEMBL3846102 0.60 AADAT (0.34) HSD17B3CYP1A2CYP2C9CYP2C19LMNA
SCHEMBL4096555 0.57 KDM4E (0.63) —
SCHEMBL68088 0.57 KDM4E (0.48) LMNA
SCHEMBL16075988 0.56 HSD17B3 (0.38) HSD17B3GRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057957-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS Takeda Pharmaceutical Company Limited (JP) 2016-08-24 — — EP disclosed
WO-2015055994-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS TAKEDA CAMBRIDGE LIMITED (GB) 2015-04-23 — — WO disclosed
Send feedback